{"data":{"id":1621,"citation":"Howell KL, DeVita RJ, Garcia-Calvo M, Meurer RD, Lisnock J, Bull HG, McMasters DR, McCann ME, Mills SG.: Spiroimidazolidinone NPC1L1 inhibitors. Part 2: structure-activity studies and in vivo efficacy. Bioorg Med Chem Lett, Volume 20 (23), 2010","title":"Spiroimidazolidinone NPC1L1 inhibitors. Part 2: structure-activity studies and in vivo efficacy.","doi":"10.1016\/j.bmcl.2010.09.138","doi_url":"https:\/\/doi.org\/10.1016\/j.bmcl.2010.09.138","pmid":"21030254","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/21030254\/","year":2010,"journal":"Bioorg Med Chem Lett","volume":"20","issue":"23","page":"6929-6932","authors":[{"first_name":"Bull HG","last_name":null,"full_name":null},{"first_name":"DeVita RJ","last_name":null,"full_name":null},{"first_name":"Garcia-Calvo M","last_name":null,"full_name":null},{"first_name":"Howell KL","last_name":null,"full_name":null},{"first_name":"Lisnock J","last_name":null,"full_name":null},{"first_name":"McCann ME","last_name":null,"full_name":null},{"first_name":"McMasters DR","last_name":null,"full_name":null},{"first_name":"Meurer RD","last_name":null,"full_name":null},{"first_name":"Mills SG.","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/1621","landing_page":"https:\/\/molmedb.upol.cz\/publication\/1621","created_at":"2021-01-20T14:30:59.000000Z","updated_at":null}}